Scarica l'app Stockscreener
0.7908
3.93%
0.0299
Pre-mercato:
.77
-0.0208
-2.63%
Precedente Chiudi:
$0.7609
Aprire:
$0.76
Volume 24 ore:
475.04K
Relative Volume:
0.56
Capitalizzazione di mercato:
$20.57M
Reddito:
$7.10M
Utile/perdita netta:
$-31.59M
Rapporto P/E:
-0.303
EPS:
-2.61
Flusso di cassa netto:
$-26.75M
1 W Prestazione:
+0.74%
1M Prestazione:
-20.92%
6M Prestazione:
-46.57%
1 anno Prestazione:
-47.28%
Intervallo 1D:
$0.757
$0.84
Intervallo di 1 settimana:
$0.7299
$0.84
Portata 52W:
$0.68
$2.88
Palatin Technologies Inc. Stock (PTN) Company Profile
Nome
Palatin Technologies Inc.
Settore
Industria
Telefono
609-495-2200
Indirizzo
Cedar Brook Corporate Center, 4B Cedar Brook Drive, Cranbury, NJ
Confronta PTN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PTN
Palatin Technologies Inc.
|
0.7908 | 20.57M | 7.10M | -31.59M | -26.75M | -2.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
504.77 | 129.62B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
666.87 | 72.91B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
604.96 | 36.76B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
241.76 | 31.30B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
259.19 | 27.86B | 3.32B | -860.46M | -1.04B | -8.32 |
Palatin Technologies Inc. Stock (PTN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2015-06-05 | Reiterato | Canaccord Genuity | Buy |
| 2015-01-12 | Reiterato | ROTH Capital | Buy |
| 2012-05-23 | Iniziato | Noble Financial | Buy |
| 2007-01-23 | Iniziato | Next Generation | Buy |
Palatin Technologies Inc. Borsa (PTN) Ultime notizie
Here's Why Palatin Technologies (PTN) Is a Great 'Buy the Bottom' Stock Now - Yahoo Finance
Palatin Technologies (NYSEAMERICAN:PTN) Shares Pass Above Two Hundred Day Moving Average – Time to Sell? - Defense World
Palatin Reports Second Quarter Fiscal Year 2025 Financial Results and Provides Business Update - GuruFocus.com
Palatin gears up for obesity treatment trials in 2025 - MSN
Palatin Awaits Data Release From Phase 2 Trial Of Bremelanotide-Tirzepatide Combo In Weight Loss - RTTNews
Palatin secures $4.7 million in stock and warrant sale By Investing.com - Investing.com Nigeria
HC Wainwright Cuts Palatin Technologies (NYSEAMERICAN:PTN) Price Target to $7.00 - Armenian Reporter
HC Wainwright Issues Pessimistic Forecast for Palatin Technologies (NYSEAMERICAN:PTN) Stock Price - Defense World
Palatin Technologies, Inc. (AMEX:PTN) Q2 2025 Earnings Call Transcript - Insider Monkey
Palatin Technologies Inc (PTN) Q2 2025 Earnings Call Highlights: Strategic Advances Amid ... - Yahoo Finance
Palatin Technologies Reports Q2 2025 Financial Results - TipRanks
Earnings call transcript: Palatin Technologies Q2 FY2025 sees stock surge By Investing.com - Investing.com Nigeria
Palatin’s Earnings Call: Mixed Results and Strategic Moves - TipRanks
Earnings call transcript: Palatin Technologies Q2 FY2025 sees stock surge - Investing.com
Palatin Technologies Q2 25 Earnings Conference Call At 11:00 AM ET - Nasdaq
Palatin Technologies Inc. Q2 Loss Decreases, Beats Estimates - Nasdaq
Palatin Slashes Quarterly Losses 70%, Obesity Drug Trial Results Imminent - StockTitan
Palatin secures $4.7 million in stock and warrant sale - MSN
Palatin Technologies (PTN) Expected to Post Earnings on Wednesday - Defense World
Palatin to Report Second Quarter Fiscal Year 2025 Results; Teleconference and Webcast to be held on February 13, 2025 - BioSpace
Palatin (PTN) Q2 Earnings: Strategic Update & Pipeline ProgressKey Details Coming Feb 13 - StockTitan
A closer look at PTN’s price-to-free cash flow ratio - US Post News
Palatin Technologies’ (PTN) Buy Rating Reiterated at HC Wainwright - Defense World
A Look at Palatin Technologies Inc (PTN) Shares in the Recent Past Indicates Growth - SETE News
Data la crescita esponenziale del settore del turismo in Arabia Saudita, dmg events annuncia il salone Hotel & Hospitality Expo - GlobeNewswire Inc.
Palatin Announces $4.7 Million Registered Direct Offering and Concurrent Private Placement - Nasdaq
PTNPalatin Tech Latest Stock News & Market Updates - StockTitan
Palatin Technologies Inc [PTN] stock for 8,274 USD was sold by WILLS STEPHEN T - Knox Daily
Palatin Gains on New Offering - Baystreet.ca
Palatin Technologies prices 4.69M shares in direct offering - MSN
Palatin Announces $4.7 Million Registered Direct Offering and Co - GuruFocus.com
Palatin Technologies Announces $4.7 Mln Direct Offering - Nasdaq
Palatin concludes Phase II trial of combination therapy for obesity - Yahoo Finance
Palatin finishes phase 2 trial in obesity treatment study By Investing.com - Investing.com Nigeria
Palatin finishes phase 2 trial in obesity treatment study - MSN
Palatin Completes Phase 2 Obesity Study With MC4R Bremelanotide Plus GLP-1/GIP Tirzepatide - GuruFocus.com
PTN’s price-to-sales ratio: A comparative analysis with its peers - US Post News
Palatin Technologies Inc (PTN) Stock: What the Analysts are Saying - The News Heater
PTN’s Market Quandary: Decoding the Ups and Downs of 2023 - The InvestChronicle
Market Watch: Palatin Technologies Inc (PTN)’s Noteworthy Drop, Closing at 0.80 - The Dwinnex
Palatin Technologies (NYSEAMERICAN:PTN) Earns “Buy” Rating from HC Wainwright - Defense World
Palatin gears up for obesity treatment trials in 2025 By Investing.com - Investing.com Canada
Palatin Technologies Inc. Azioni (PTN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):